Pattern and severity of left ventricular diastolic dysfunction in early and end stage renal disease patients with or without dialysis in rural population in South India

Prashant S. Sidmal, Mallikarjun HP, Shekarappa KC

Abstract


Objective: Our aim was to investigate whether renal insufficiency (RI) is associated with DD among patients with left ventricular ejection fraction (LVEF) > 50%, and to investigate whether there is a correlation between CKD and DD severity.

Methods: Eighty four CKD patients, aged 35-79 were examined by standard echocardiography. Subjects were divided into 4 groups depending on their estimated glomerular filtration rate (eGFR: ml/min/BSA) as follows:  group 1 (60—89 ml/min/BSA), group 2 (30—59 ml/min/BSA), group 3 (15—29 ml/min/BSA) and group 4 (less than 15 ml/min/BSA), between 1/2/2014 and 30/4/2015. Glomerular filtration rate (GFR) was estimated using the MDRD formula. Patients with impaired relaxation (grade I) were compared to those with pseudonormal (grade II) or restrictive (grade III-IV) DD.

Results: Among 84 patients, 23 had GFR 60-89 ml/min/BSA; 16 had GFR 30-59 ml/min/BSA; and 19 had GFR 15-30 ml/min/BSA and 26 had GFR <15 ml/min/BSA. There was a significant correlation between worsening GFR and degree of diastolic dysfunction (DD) assessed by echo. Overall, 40.4% of the participants were female, 22 (26.1 %) had grade I, & 10 (11.9 %) had grade II, 16 (19%) had grade III and 36 (42.8%) had grade IV diastolic dysfunction. Almost all patients had some degree of diastolic dysfunction. With worsening of renal function, there was worsening of diastolic dysfunction seen. In patients with end stage renal disease many had grade IV diastolic dysfunction as compared to patients with early CKD. Grade I and II DD was commonly seen in group 1 and 2. But grade III and IV DD was commonly seen in group 3 and 4. 

Conclusion: Worsening renal function was associated with greater degree of diastolic dysfunction and adverse clinical outcomes. Our Study indicated a clear and independent association between RI and DD. The severity of RI also tends to correlate with the severity of DD. And that LV diastolic dysfunction was observed even in patients with early stages of chronic kidney dysfunction.


Keywords


Chronic kidney disease, Echocardiography, Diastolic function, cardiovascular disease

Full Text:

PDF

References


Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296–1305, 2004

. Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD,Chang PP, Chambless LE, Coresh J: Reduced kidney function as a risk factor for incident heart failure: The atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol 18: 1307–1315, 2007

. Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB: Renal insufficiency as a predictor of cardio- vascular outcomes and mortality in elderly individuals. J Am Coll Car- diol 41: 1364–1372, 2003

. Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM,Newman AB, Siscovick D, Shlipak MG, Cardiovascular Health S; Car- diovascular Health Study: Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 142: 497–505, 2005

. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS: Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly per- sons without chronic kidney disease. Ann Intern Med 145: 237–246, 2006

. Stevens LA, Coresh J, Schmid CH, Feldman HI,

Froissart M, Kusek J, Rossert J, Van Lente F, Bruce RD 3rd, Zhang YL, Greene T, Levey AS: Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 51: 395–406, 2008

. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA,

Braam B: The severe cardiorenal syndrome: ‘Guyton revisited.’ Eur Heart J 26: 11–17, 2005

. Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G: Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis 46: 320–327, 2005

. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O: Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 34: 125–134, 1999

. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186–192, 1995

. Nardi E, Palermo A, Mulè G, Cusimano P, Cottone S, Cerasola G: Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens 27: 633–641, 2009

. Otsuka T, Suzuki M, Yoshikawa H, Sugi K: Left ventricular diastolic dysfunction in the early stage of chronic kidney disease. J Cardiol 54: 199–204, 2009

. Nardi E, Cottone S, Mulè G, Palermo A, Cusimano P, Cerasola G: In- fluence of chronic renal insufficiency on left ventricular diastolic func- tion in hypertensives without left ventricular hypertrophy. J Nephrol 20: 320–328, 2007

. Khan NA, Ma I, Thompson CR, Humphries K, Salem DN, Sarnak MJ, Levin A. Kidney function and mortality among patients with left ventricular systolic function. J Am Soc Nephrol 2006;17:244—53.

. McAlister FA, Ezkowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004—9.

. Dries DL, Exner DV, Domanski MJ, Greenberg B, Steven- son LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ven- tricular systolic dysfunction. J Am Coll Cardiol 2000;35:

. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ. Renal function, neurohormonal activation, and sur- vival in patients with chronic heart failure. Circulation 2000;102:203—10.

. Nishimura RA, Tajik AJ. Evaluation diastolic filling of left ventricle in health and disease: Doppler echocardiogra- phy is the clinician’s Rosetta Stone. J Am Coll Cardiol 1997;30:8—18.

. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quin˜ones MA. Doppler tissue imaging a noninvasive technique for evaluation of the left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527—33.

. Bruch C, Rothenburger M, Gotzmann M, Wichter T, Scheld HH, Breithardt G, Gradaus R. Chronic kidney disease in patients with chronic heart failure: impact on intracardiac conduction, diastolic function and prognosis. Int J Cardiol 2007;118:375—80.

. Glassock RJ, Pecoits-Filho R, Barberato SH: Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 2009;4(suppl 1):S79–S91.

. London GM: Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 2003;16: 85–94.

. London GM, Parfrey PS: Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace Ther 1997;4:194–211.

. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996;28:53–61.

. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, et al: US renal data system 2010 annual data report. Am J Kidney Dis 2011, 57(1 Suppl 1):A8. e1-526.

. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, et al: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108(17):2154–2169.

. Meeus F, Kourilsky O, Guerin AP, Gaudry C, Marchais SJ, London GM: Pathophysiology of cardiovascular disease in hemodialysis patients. Kidney Int Suppl 2000, 76:S140–S147.

. Dyadyk OI, Bagriy AE, Yarovaya NF: Disorders of left ventricular structure and function in chronic uremia: how often, why and what to do with it? Eur J Heart Fail 1999, 1(4):327–336.

. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM: Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002, 39(4):695–701.

. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, Sanderson JE: Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 2003, 14(1):159–168.

. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE: Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 2000, 11(5):912–916.

. Alpert MA: Cardiac performance and morphology in end-stage renal disease. Am J Med Sci 2003, 325(4):168–178.

. Pecoits-Filho R, Barberato SH: Echocardiography in chronic kidney disease: diagnostic and prognostic implications. Nephron Clin Pract 2010, 114(4):c242–c247.

. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011—53.

. National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classifi- cation, and stratification. Am J Kidney Dis 2002;2(Suppl. 1): S46-7.

. Levey AS, Bosch JP, Lewis JP, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461—70.

. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricular by the two-dimensional echocardiography. American Society of Echocardiography committee on Standards, subcommit- tee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989;2:358—67.

. Labovitz AJ, Pearson AC. Evaluation of left ventricular diastolic function: clinical relevance and recent Doppler echocardiographic insight. Am Heart J 1987;114:836—51.

. Appleton CP, Hantle L, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function. J Am Coll Cardiol 1988;12:426—40.

. Pappas KD, Gouva CD, Katopodis KP, Nikolopoulos PM, Korantzopoulos PG, Michalis LM, goudevenos JA, Siamopou- los KC. Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effect on cardiac performance. Cardiovasc Drugs Ther 2008;22:37—44.

.M. F. Stoddard, A. C. Pearson, M. J. Kern, J. Ratcliff, D. G. Mrosek, and A. J. Labovitz, “Influence of alteration in preload on the pattern of left ventricular diastolic filling as assessed by Doppler echocardiography in humans,” Circulation, vol. 79, no. 6, pp. 1226–1236, 1989

. Aurigemma G, Zile M, Gaasch W: Contractile behavior of the left ventricle in diastolic heart failure: with emphasis on regional systolic function. Circulation 2006;113:296–304.

. Nikitin N, Witte KK, Clark AL, Cleland JG: Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function. Am J Cardiol 2002;90:1174–1177.

. Daskalov IR, Petrovsky PD, Demirevska LD: Mitral annular systolic velocity as a marker of preclinical systolic dysfunction among patients with arterial hypertension. Cardiovasc Ultrasound 2012;10:46.

. Khan NA, Ma I, Thompson CR, Humphries K, Salem DN, Sarnak MJ, Levin A. Kidney function and mortality among patients with left ventricular systolic function. J Am Soc Nephrol 2006;17:244—53.

. Dries DL, Exner DV, Domanski MJ, Greenberg B, Steven- son LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ven- tricular systolic dysfunction. J Am Coll Cardiol 2000;35: 681—9.

. Lim Y-J, Yamamoto K, Ichikawa M, Iwata A, Hayashi T, Nakata T, Masuyama T, Mishima M. Elevation of the ratio of transmitral E velocity to early diastolic mitral annu- lar velocity continues even after recovery from acute stage in patients with diastolic heart failure. J Cardiol 2008;52:254—60.

. Fonarow GC, Heywood JT. The confounding issue of comor- bid renal insufficiency. Am J Med 2006;119:S17—25.

. Krumholz HM, Chen YT, Wang Y, Vaccarino V, Radford MJ, Horwitz RI. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J 2000;139:72—7.

. Akhter MW, Aronson D, Bitar F, Khan S, Singh H, Singh RP, Burger AJ, Elkayam U. Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure. Am J Cardiol 2004;94:957—60.

. Ishida Y, Meisner JS, Tsujioka K, Gallo JI, Yoran C, Frater RW, Yellin EL. Left ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure. Circulation 1986;74:187—96.

. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, et al: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108(17):2154–2169.

. Meeus F, Kourilsky O, Guerin AP, Gaudry C, Marchais SJ, London GM: Pathophysiology of cardiovascular disease in hemodialysis patients. Kidney Int Suppl 2000, 76:S140–S147.

. Dyadyk OI, Bagriy AE, Yarovaya NF: Disorders of left ventricular structure and function in chronic uremia: how often, why and what to do with it? Eur J Heart Fail 1999, 1(4):327–336.

. Mall G, Huther W, Schneider J, Lundin P, Ritz E: Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 1990, 5(1):39–44.

. Amann K, Ritz E: The heart in renal failure: morphological changes of the myocardium - new insights. J Clin Basic Cardiol 2001, 4:109–113.

. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995, 5(12):2024–2031.

. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS: Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001, 12(12):2768–2774.

. Takase H, Dohi Y, Toriyama T, Okado T, Tanaka S, Shinbo H, Kimura G: B-type natriuretic peptide levels and cardiovascular risk in patients with diastolic dysfunction on chronic haemodialysis: cross-sectional and observational studies. Nephrol Dial Transplant 2010, 26(2):683–690.

. Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ: Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart 2006, 92(6):804–809.

. Rakhit DJ, Zhang XH, Leano R, Armstrong KA, Isbel NM, Marwick TH: Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease. Am Heart J 2007, 153(4):656–664.

. Park M, Hsu C-y, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, et al: Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 2012, 23(10):1725–1734.

. Losi MA, Memoli B, Contaldi C, Barbati G, del Prete M, Betocchi S, Cavallaro M, Carpinella G, Fundaliotis A, Parrella LS, et al: Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis. Nephrol Dial Transplant 2010, 25(6):1950–1954.




DOI: http://dx.doi.org/10.7439/ijbr.v6i8.2358

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Refbacks

  • There are currently no refbacks.




Copyright (c) 2015 International Journal of Biomedical Research

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.